UnitedHealth Group Incorporated is upgraded to Strong Buy due to margin recovery and robust EPS expansion. Learn more about UNH stock here.

UNH tops Q4 EPS estimates as Optum Rx drove growth, but profits plunged year over year, and management set a cautious 2026 ...

UnitedHealth Group's shares tumbled premarket as the company reported $10 million in profit for the fourth quarter of 2025.

UnitedHealth Group (NYSE:UNH) reported fourth-quarter and full-year 2025 earnings this morning that fell slightly short of analyst estimates, while offering guidance for the coming year that indicated ...

The upcoming advance notice for Medicare Advantage rates is a pivotal moment for UnitedHealth. Analysts at Mizuho have reiterated a 'Buy' rating, forecasting a rate growth of 5% or more, with the ...

UnitedHealth (UNH) stock and its peers drop as the company posts Q4 revenue missing the consensus, and its 2026 revenue ...